Michael Melicher

Michael Melicher, Ph.D., has a diverse work experience that spans various roles in the fields of insights and analytics, consulting, research, and teaching.

Michael is currently employed as the Director of Insights and Analytics at Sage Therapeutics since March 2023, where they are responsible for overseeing strategic insights and analytics initiatives. Prior to this role, they served as the Associate Director of Commercial Insights and Analytics at the same company from January 2022 to March 2023.

Before joining Sage Therapeutics, Michael worked as a Senior Consultant at TRINITY from December 2020 to January 2022, where they contributed to consulting projects.

Michael also gained experience as a Consultant and Senior Associate at BluePrint Research Group from July 2018 to December 2020, where they contributed to various consulting projects.

In addition, Michael served as an Intern at Partners HealthCare Innovation from January 2018 to May 2018, where they gained firsthand experience in the healthcare industry.

Michael also worked as a Postdoctoral Fellow at Walker Lab from August 2015 to February 2017, where they conducted research in their field of expertise.

Furthermore, Michael demonstrated leadership skills as a Team Leader in the Commercializing Science Field Course from August 2016 to December 2016. Michael led a team of Harvard MBAs and Ph.D.s in producing a clinical development and market commercialization plan for a Harvard intellectual property in the type 1 diabetes space.

Michael also has experience in teaching as a Teaching Fellow at Yale from September 2011 to June 2015. During this time, they contributed to the teaching and mentoring of students.

Additionally, they worked as a Graduate Student at Schepartz Lab from May 2011 to June 2015. In this role, they explored the use of beta-peptide bundles as potential scaffolds for artificial glycosidases and managed collaborations with other departments.

Before pursuing their Ph.D., Michael served as an Undergraduate Research Technician at Chruma Lab from January 2008 to May 2010.

Lastly, they gained experience in teaching as a Teaching Assistant at the University of Virginia from August 2009 to December 2009, where they led recitation sections, graded assignments and exams.

Overall, Michael Melicher has a strong background in insights and analytics, consulting, research, and teaching, showcasing their versatility and expertise in various professional settings.

Michael Melicher, Ph.D. obtained their Bachelor of Science degree in Chemistry and Biochemistry from the University of Virginia (UVa), College of Arts and Sciences from 2006 to 2010. Following their undergraduate studies, they pursued a Ph.D. in Chemical Biology at Yale University from 2010 to 2015. Additionally, they attended the McIntire Business Institute at the University of Virginia, though the dates and field of study for this program were not specified.